about
Lysine supplementation is not effective for the prevention or treatment of feline herpesvirus 1 infection in cats: a systematic reviewThe role of innate APOBEC3G and adaptive AID immune responses in HLA-HIV/SIV immunized SHIV infected macaquesThe mRNA-bound proteome of the human malaria parasite Plasmodium falciparumGenome-wide mapping of DNA methylation in the human malaria parasite Plasmodium falciparumResponsiveness of cats (Felidae) to silver vine (Actinidia polygama), Tatarian honeysuckle (Lonicera tatarica), valerian (Valeriana officinalis) and catnip (Nepeta cataria).The multifunctional autophagy pathway in the human malaria parasite, Plasmodium falciparum.Three-dimensional modeling of the P. falciparum genome during the erythrocytic cycle reveals a strong connection between genome architecture and gene expressionDNA-encoded nucleosome occupancy is associated with transcription levels in the human malaria parasite Plasmodium falciparum.Rapid escape from preserved cross-reactive neutralizing humoral immunity without loss of viral fitness in HIV-1-infected progressors and long-term nonprogressorsPolysome profiling reveals translational control of gene expression in the human malaria parasite Plasmodium falciparumSingle nucleotide polymorphism in gene encoding transcription factor Prep1 is associated with HIV-1-associated dementia.PuFFIN--a parameter-free method to build nucleosome maps from paired-end reads.Polymorphism in HIV-1 dependency factor PDE8A affects mRNA level and HIV-1 replication in primary macrophages.Characterization of cereal toxicity for celiac disease patients based on protein homology in grains.Immunization with recombinant HLA classes I and II, HIV-1 gp140, and SIV p27 elicits protection against heterologous SHIV infection in rhesus macaques.Activity of broadly neutralizing antibodies, including PG9, PG16, and VRC01, against recently transmitted subtype B HIV-1 variants from early and late in the epidemicLonger V1V2 region with increased number of potential N-linked glycosylation sites in the HIV-1 envelope glycoprotein protects against HIV-specific neutralizing antibodies.Multiple dimensions of epigenetic gene regulation in the malaria parasite Plasmodium falciparum: gene regulation via histone modifications, nucleosome positioning and nuclear architecture in P. falciparumIncreased neutralization sensitivity of recently emerged CXCR4-using human immunodeficiency virus type 1 strains compared to coexisting CCR5-using variants from the same patient.Analysis of nucleosome positioning landscapes enables gene discovery in the human malaria parasite Plasmodium falciparum.PfAlba1: master regulator of translation in the malaria parasite.The Role of Chromatin Structure in Gene Regulation of the Human Malaria Parasite.Dynamic and Combinatorial Landscape of Histone Modifications during the Intraerythrocytic Developmental Cycle of the Malaria Parasite.Development of a replication-deficient adenoviral vector-based vaccine candidate for the interception of HPV16- and HPV18-induced infections and disease.Changing sensitivity to broadly neutralizing antibodies b12, 2G12, 2F5, and 4E10 of primary subtype B human immunodeficiency virus type 1 variants in the natural course of infection.Emergence of monoclonal antibody b12-resistant human immunodeficiency virus type 1 variants during natural infection in the absence of humoral or cellular immune pressure.Escape from autologous humoral immunity of HIV-1 is not associated with a decrease in replicative capacity.Immunization with recombinant macaque major histocompatibility complex class I and II and human immunodeficiency virus gp140 inhibits simian-human immunodeficiency virus infection in macaques.Escape of human immunodeficiency virus type 1 from broadly neutralizing antibodies is not associated with a reduction of viral replicative capacity in vitro.P09-14. Emergence of b12 resistant rapidly replication HIV-1 variants during natural infection in the absence of humoral or cellular immune pressure.Nascent RNA sequencing reveals mechanisms of gene regulation in the human malaria parasite Plasmodium falciparum.P19-08. Immunisation with recombinant HLA class I and II, HIV-1gp140 and SIVp27 antigens elicits protection against SHIV-SF162P4 infection in rhesus macaques.P19-20. Allogeneic stimulation of the anti-viral APOBEC3G in human CD4+ T cells and prevention of SHIV infectivity in macaques immunized with HLA antigens.P04-49 LB. Adaptation of HIV-1 envelope glycoprotein to humoral immunity at a population level.Cross‐Reactive Neutralizing Humoral Immunity Does Not Protect from HIV Type 1 Disease ProgressionAdaptation of HIV-1 envelope gp120 to humoral immunity at a population level
P50
Q22000632-21E561EE-E8A5-4C1E-BA29-255D451CB81AQ27305204-0F9456B4-1D9D-4037-9C85-B813892EBCF9Q27972581-7149D3B9-5421-4E3B-A4F5-F71554CD999FQ27972932-C9D2F2E2-FC8C-4222-BDD7-5B9F6CE7B966Q30842192-7143B1C0-6FAC-4A73-B84F-3A50C61310FBQ33638641-3D37365D-E329-464A-ACA3-9AD6FD5E7C83Q33657762-7BAE82E6-A4EC-4A57-999D-E02EAC8F725AQ33669258-7CA4DD37-0A9A-49E4-8C1A-1219DED9C57DQ33725673-7D0055D3-6B0F-42C9-840E-E071C2268C85Q33741784-86D19321-4030-4DB4-9FA2-BB4B3CE84820Q34162648-14CC206C-CC27-4151-B34A-17675C21838DQ34211315-2F158CCB-F446-447E-826F-BF4A1FF7DEB0Q34216644-31EBC682-F54A-40BF-9CEC-ECF04CD7E091Q34266102-ADF774A4-EA56-4918-A338-B588710AC11AQ35077438-B1DC88F1-57EF-42D2-9DFE-4331C3A84601Q35077704-FC00EBD7-2948-4E63-B5BD-922B48B046AAQ35077797-15E66F55-2F44-4D0D-9E83-FE80D1DBAB0FQ35272932-FDEB5BE8-EF24-4EF5-99AF-DBCD8A5A7A19Q35634988-82A7C3FB-458C-4B32-89AC-FE1ED466315FQ35852936-F8152D69-5DDF-43EA-A5A7-A5149427E77BQ36141064-45480D75-9908-4144-9823-13DA9FFAC1EFQ39074906-A49105F5-B03D-43C1-8A67-F0B096F7F55AQ39690333-A0FAF4E7-078A-474C-99A4-13BE5260690CQ40306609-4E5DA3C7-EABC-43DC-9261-5AA545D0C7B3Q44176443-51EC5B70-7472-47CC-AB85-CF7EB3A1027FQ44679186-97CECDF4-CAA1-402E-8F9A-DB508A3B5351Q44775993-5DDC6792-3EC0-458A-AD1A-C527EE24AB2DQ45358427-4FD7996C-1C71-4FF0-99D9-0A4C5C5EE7DBQ45406304-C324959E-C793-4120-AF1B-C74500D1363DQ45894031-32406758-BB37-4187-9B97-51B76305321DQ45963302-29C803E0-1DEE-4785-B862-4FFED9E0D922Q46515248-EEBDA89B-E649-45ED-AD04-654E0DE1EC0FQ47108515-FC126893-A191-41E5-B52D-63523C185B1DQ47131034-B3CB9A9B-35FB-41D0-8DC2-FD5374D6F7EAQ56886558-4067330E-AB33-427B-86D7-F301F7E05DFEQ58038022-2FD67A5A-A8CD-4B8C-BA94-C5CCAEB67681
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Evelien M. Bunnik
@ast
Evelien M. Bunnik
@en
Evelien M. Bunnik
@es
Evelien M. Bunnik
@nl
Evelien M. Bunnik
@sl
type
label
Evelien M. Bunnik
@ast
Evelien M. Bunnik
@en
Evelien M. Bunnik
@es
Evelien M. Bunnik
@nl
Evelien M. Bunnik
@sl
prefLabel
Evelien M. Bunnik
@ast
Evelien M. Bunnik
@en
Evelien M. Bunnik
@es
Evelien M. Bunnik
@nl
Evelien M. Bunnik
@sl
P106
P1153
55892064600
P31
P496
0000-0003-4003-3053